Sort   by:  
 Page size 
UnknownLifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.
Not available
S-EPMC10165492 | biostudies-literature
UnknownValidated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.
Not available
S-EPMC9544180 | biostudies-literature
UnknownGene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.
Not available
S-EPMC9751776 | biostudies-literature
UnknownConcurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.
Not available
S-EPMC11325151 | biostudies-literature
UnknownConcurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.
Not available
S-EPMC10659507 | biostudies-literature
Unknownp53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.
Not available
S-EPMC10073933 | biostudies-literature
UnknownBeyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i>-deficient tubo-ovarian high-grade serous carcinoma.
Not available
S-EPMC12486008 | biostudies-literature
UnknownPrognostic gene expression signature for high-grade serous ovarian cancer.
Not available
S-EPMC7484370 | biostudies-literature
Sort   by:  
 Page size